214 related articles for article (PubMed ID: 29662154)
21. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome.
Mehyar M; Mosallam M; Tbakhi A; Saab A; Sultan I; Deebajah R; Jaradat I; AlJabari R; Mohammad M; AlNawaiseh I; Al-Hussaini M; Yousef YA
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):152-159. PubMed ID: 32222358
[TBL] [Abstract][Full Text] [Related]
22. RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR).
Kugalingam N; De Silva D; Abeysekera H; Nanayakkara S; Tirimanne S; Ranaweera D; Suravajhala P; Chandrasekharan V
BMC Med Genomics; 2023 Nov; 16(1):279. PubMed ID: 37932687
[TBL] [Abstract][Full Text] [Related]
23. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
[No Abstract] [Full Text] [Related]
24. Simultaneous identification of clinically relevant
Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
[TBL] [Abstract][Full Text] [Related]
25. A splicing mutation in RB1 in low penetrance retinoblastoma.
Schubert EL; Strong LC; Hansen MF
Hum Genet; 1997 Oct; 100(5-6):557-63. PubMed ID: 9341870
[TBL] [Abstract][Full Text] [Related]
26. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy.
Chaussade A; Millot G; Wells C; Brisse H; Laé M; Savignoni A; Desjardins L; Dendale R; Doz F; Aerts I; Jimenez I; Cassoux N; Stoppa Lyonnet D; Gauthier Villars M; Houdayer C
Eur J Med Genet; 2019 Mar; 62(3):217-223. PubMed ID: 30031154
[TBL] [Abstract][Full Text] [Related]
27. Genetic screening in patients with Retinoblastoma in Israel.
Sagi M; Frenkel A; Eilat A; Weinberg N; Frenkel S; Pe'er J; Abeliovich D; Lerer I
Fam Cancer; 2015 Sep; 14(3):471-80. PubMed ID: 25754945
[TBL] [Abstract][Full Text] [Related]
28. Factors for improved genetic counseling for retinoblastoma based on a survey of 55 families.
Carlson EA; Letson RD; Ramsay NK; Desnick RJ
Am J Ophthalmol; 1979 Apr; 87(4):449-59. PubMed ID: 443309
[TBL] [Abstract][Full Text] [Related]
29. Mutational mosaicism and genetic counseling in retinoblastoma.
Carlson EA; Desnick RJ
Am J Med Genet; 1979; 4(4):365-81. PubMed ID: 120116
[TBL] [Abstract][Full Text] [Related]
30. Defective splicing of the RB1 transcript is the dominant cause of retinoblastomas.
Cygan KJ; Soemedi R; Rhine CL; Profeta A; Murphy EL; Murray MF; Fairbrother WG
Hum Genet; 2017 Sep; 136(9):1303-1312. PubMed ID: 28780672
[TBL] [Abstract][Full Text] [Related]
31. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan.
Zhang Z; Xiao YS; Shen R; Jiang HC; Tan L; Li RQ; Yang XH; Gu HY; He WJ; Ma J
BMC Med Genet; 2020 Nov; 21(1):230. PubMed ID: 33225895
[TBL] [Abstract][Full Text] [Related]
32. Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis.
Abouzeid H; Schorderet DF; Balmer A; Munier FL
Mol Vis; 2009; 15():771-7. PubMed ID: 19390654
[TBL] [Abstract][Full Text] [Related]
33. The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma.
Ketteler P; Hülsenbeck I; Frank M; Schmidt B; Jöckel KH; Lohmann DR
Eur J Cancer; 2020 Jul; 133():47-55. PubMed ID: 32434110
[TBL] [Abstract][Full Text] [Related]
34. Evidence of predisposing epimutation in retinoblastoma.
Gelli E; Pinto AM; Somma S; Imperatore V; Cannone MG; Hadjistilianou T; De Francesco S; Galimberti D; Currò A; Bruttini M; Mari F; Renieri A; Ariani F
Hum Mutat; 2019 Feb; 40(2):201-206. PubMed ID: 30427563
[TBL] [Abstract][Full Text] [Related]
35. [Molecular diagnosis of retinoblastoma: molecular epidemiology and genetic counseling].
Alonso J; Palacios I; Gámez A; Camino I; Frayle H; Menéndez I; Kontic M; García-Miguel P; Sastre A; Abelairas J; Sarret E; Sabado C; Navajas A; Artigas M; Indiano JM; Carbone A; Rosell J; Pestaña A
Med Clin (Barc); 2006 Mar; 126(11):401-5. PubMed ID: 16595082
[TBL] [Abstract][Full Text] [Related]
36. [Low-penetrance retinoblastoma due to exons 24 and 25 deletions in the Rb1 gene].
Du C; Jiang Y; Gallie BL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):370-4. PubMed ID: 12362308
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
38. RB1 mutation spectrum in a comprehensive nationwide cohort of retinoblastoma patients.
Dommering CJ; Mol BM; Moll AC; Burton M; Cloos J; Dorsman JC; Meijers-Heijboer H; van der Hout AH
J Med Genet; 2014 Jun; 51(6):366-74. PubMed ID: 24688104
[TBL] [Abstract][Full Text] [Related]
39. Unilateral retinocytoma associated with a variant in the RB1 gene.
Wu S; Zou X; Sun Z; Zhu T; Wei X; Sui R
Mol Genet Genomic Med; 2020 Apr; 8(4):e1156. PubMed ID: 31997559
[TBL] [Abstract][Full Text] [Related]
40. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
Schieffer KM; Feldman AZ; Kautto EA; McGrath S; Miller AR; Hernandez-Gonzalez ME; LaHaye S; Miller KE; Koboldt DC; Brennan P; Kelly B; Wetzel A; Agarwal V; Shatara M; Conley S; Rodriguez DP; Abu-Arja R; Shaikhkhalil A; Snuderl M; Orr BA; Finlay JL; Osorio DS; Drapeau AI; Leonard JR; Pierson CR; White P; Magrini V; Mardis ER; Wilson RK; Cottrell CE; Boué DR
Acta Neuropathol Commun; 2021 Apr; 9(1):61. PubMed ID: 33827698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
